Val D Or

Researchers are evaluating the safety and effectiveness of a fractional ablative 2940 nm laser treatment for women with biopsy-confirmed vulvar lichen sclerosus lesions. This condition may cause symptoms like dryness, itching, burning, bleeding, and painful intercourse, which this study aims to address. The study focuses on adult females aged 18 years or older who have these symptoms and lesions. The treatment under study uses a fractional 2940 nm laser applied to the affected vulvar area. Participants will receive this laser therapy during the study period. The goal is to assess histological clearance of the lichen sclerosus lesions after 16 weeks of treatment. There are no additional study drugs or comparators mentioned. Participants will be involved in consenting to clinical photography and ultrasound imaging of the treatment area. They will also complete questionnaires and follow a schedule of treatments and follow-up visits. Researchers will monitor lesion clearance through tissue examination and observe any side effects or safety concerns throughout the study duration.